SHIRE LTD: No Hearing Date Yet for VYVANSE Appeal
A hearing date has yet to be set on Actavis Elizabeth LLC’s appeal regarding the U.S. District Court for the District of Columbia’s ruling on VYVANSE, according to Shire Ltd.’s…
A hearing date has yet to be set on Actavis Elizabeth LLC’s appeal regarding the U.S. District Court for the District of Columbia’s ruling on VYVANSE, according to Shire Ltd.’s…
A jury ruling on The Western Union Company’s patent infringement suit against MoneyGram Payment Systems, Inc. is on appeal to the United States Court of Appeals for the Federal Circuit.
In…
KeyBank National Association, KeyCorp’s subsidiary, continues to defend itself against DataTreasury Corporation’s patent infringement suit.
In February 2006, an action styled DataTreasury Corporation v. Wells Fargo & Company, et al., was…
Shire Ltd. is defending itself against Mt. Sinai School of Medicine of New York University’s patent infringement lawsuits in Sweden and Germany.
On April 14, 2010, Mt. Sinai sought to initiate…
Interactive Brokers Group, Inc. intends to defend itself against a patent infringement suit brought by Trading Technologies International, Inc.
On February 3, 2010, Trading Technologies filed a complaint in the United…
Litigation between AU Optronics Corp. and Plasma Physics Corp. and Solar Physics Corp. for alleged infringement of patents relating to AKT America Inc.’s machines was settled in October 2009.
In April…
Generics UK Ltd.’s appeal regarding the ruling in its rectification action against Shire Ltd. remains pending.
Generics UK seeks a declaration that the duration of the Supplementary Protection Certificate for European…
Litigation between AU Optronics Corp. and Honeywell International Inc. and Honeywell Intellectual Properties Inc. for the alleged infringement of patents relating to the manufacture of TFT-LCD panels was settled in…
No trial date has been set for Shire Ltd.’s patent infringement suits against Barr, Mylan, Inc., Mylan Pharmaceuticals, Inc., and Matrix Laboratories, Inc., and Natco Pharma Limited.
In February 2009, Shire…
Shire Ltd.’s suit against Nostrum Pharmaceuticals, Inc., relating to their ANDAs seeking approval to market generic versions of 100mg, 200mg and 300mg strengths of CARBATROL was settled on March 10,…